BBR Partners’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,202
| Closed | -$88.3K | – | 258 |
|
|
2025
Q1 | $88.3K | Hold |
8,202
| – | – | 0.01% | 233 |
|
|
2024
Q4 | $105K | Hold |
8,202
| – | – | 0.01% | 238 |
|
|
2024
Q3 | $226K | Hold |
8,202
| – | – | 0.02% | 208 |
|
|
2024
Q2 | $238K | Hold |
8,202
| – | – | 0.02% | 186 |
|
|
2024
Q1 | $366K | Hold |
8,202
| – | – | 0.03% | 169 |
|
|
2023
Q4 | $318K | Hold |
8,202
| – | – | 0.03% | 137 |
|
|
2023
Q3 | $241K | Hold |
8,202
| – | – | 0.03% | 163 |
|
|
2023
Q2 | $522K | Hold |
8,202
| – | – | 0.06% | 99 |
|
|
2023
Q1 | $387K | Hold |
8,202
| – | – | 0.04% | 110 |
|
|
2022
Q4 | $569K | Hold |
8,202
| – | – | 0.06% | 97 |
|
|
2022
Q3 | $1.2M | Hold |
8,202
| – | – | 0.15% | 65 |
|
|
2022
Q2 | $1.07M | Hold |
8,202
| – | – | 0.13% | 72 |
|
|
2022
Q1 | $828K | Hold |
8,202
| – | – | 0.08% | 106 |
|
|
2021
Q4 | $1.27M | Buy |
+8,202
| New | +$1.27M | 0.15% | 74 |
|